Huete, Lanz Asher A.

HRN: 21-11-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFTRIAXONE 1G (VIAL)
05/27/2022
06/02/2022
IV
1gm
Q24h
PCAP-C
Waiting Final Action 
05/27/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/27/2022
06/02/2022
IV
1000mg
Q6h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: